Meropenem Injection
Sponsors
Hannover Medical School, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Ziauddin University, Tongji Hospital, Mohamed Gaber Allam
Conditions
Acute-On-Chronic Liver FailureAntibodies Drug SpecificCholangitis, Secondary BiliaryDrug ToxicityEnteric FeverLiver CirrhosisNeutropenic FeverPatients With Respiratory Failure and Shocked
Phase 1
Phase 2
Phase 4
Efficacy and Pharmacokinetics of Meropenem in Severe Septic Patients
CompletedNCT03645668
Start: 2018-01-30End: 2019-12-14Updated: 2020-03-13
Comparison of Two Drugs Regimen in Treatment of Complicated Typhoid Fever in Children
CompletedNCT04154722
Start: 2019-06-20End: 2020-12-30Updated: 2021-06-16
Antibiotics Treatment of Cholangitis Post-Kasai Portoenterostomy
CompletedNCT04370145
Start: 2021-05-01End: 2022-04-01Updated: 2022-04-11
Antidote for Valproic Acid Toxicity: a New Indication for Meropenem Antibiotic.
NCT04671589
Start: 2021-06-30End: 2022-12-31Target: 48Updated: 2020-12-17
Fast-track Blood Test for Suspected Fever by Deficiency of a Kind of White Blood Cells As Main Defense Against Infection
NCT05393505
Start: 2022-10-24End: 2025-06-30Target: 344Updated: 2022-12-06
Meropenem vs Azithromycin Efficacy in Case XDR Enteric Fever
RecruitingNCT07314281
Start: 2025-04-22End: 2025-12-31Target: 40Updated: 2026-01-02
Unknown Phase
Meropenem Pharmacokinetics in Spontaneous Bacterial Peritonitis
NCT03571711
Start: 2018-06-28End: 2021-01-01Target: 15Updated: 2019-08-07
Comparison of Efficacy and Safety of Ceftazidime Avibactam Versus Extended Infusions of High Dose Meropenem in Patients of ACLF With Nosocomial Infections.
Not yet recruitingNCT06818565
Start: 2025-02-10End: 2026-12-31Target: 150Updated: 2025-02-10